z-logo
Premium
Guide‐wire fragment embolisation in paediatric peripherally inserted central catheters
Author(s) -
Dulhunty Joel M,
Suhrbier Andreas,
Macaulay Graeme A,
Brett Jennifer C,
Van Straaten Alexa V A,
Brereton Ian M,
Farmer Jillann F
Publication year - 2012
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja12.10097
Subject(s) - peripherally inserted central catheter , fragment (logic) , medicine , surgery , catheter , computer science , programming language
Objective: To report guide‐wire fragment embolisation of paediatric peripherally inserted central catheter (PICC) devices and explore the safety profile of four commonly used devices. Design, setting and participants: Clinical incidents involving paediatric PICC devices in Queensland public hospitals were reviewed. A PICC user‐experience survey was conducted at five public hospitals with 32 clinicians. A device design evaluation was undertaken, and magnetic resonance imaging (MRI) safety was tested by a simulation study. Main outcome measures: Embolisation events; technical mistakes, multiple attempts and breakages during insertion; willingness to use the device; failure modes and risk priority rating; movement and/or temperature change on exposure to MRI. Results: Six clinical incidents of silent guide‐wire embolisation, and four near misses were identified; all were associated with one type of device. The survey found that this device had a reported broken‐wire embolisation rate of 0.9/100 insertions with no events in other devices; two of the four devices had a higher all‐cause embolisation rate (3.3/100 insertions v 0.4/100 insertions) and lower clinician acceptance (68%–71% v 91%–100%). All devices had 6–17 identified failure modes; the two devices that allowed removal of a guide wire through a septum had the highest overall risk rating. Guide‐wire exposure to MRI was rated a potential safety risk due to movement. Conclusions: There is marked variation in the safety profile of 3 Fr PICC devices in clinical use, and safety performance can be linked to design factors. Pre‐MRI screening of all children who have previously had a PICC device inserted is recommended. We advocate a decision‐making model for evaluation of device safety.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom